Jennison Associates’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-338,509
| Closed | -$18M | – | 680 |
|
|
2017
Q3 | $18M | Sell |
338,509
-131,523
| -28% | -$7M | 0.02% | 416 |
|
|
2017
Q2 | $29.2M | Sell |
470,032
-30,258
| -6% | -$1.88M | 0.03% | 343 |
|
|
2017
Q1 | $33.9M | Hold |
500,290
| – | – | 0.04% | 334 |
|
|
2016
Q4 | $35.2M | Buy |
500,290
+1,844
| +0.4% | +$130K | 0.04% | 321 |
|
|
2016
Q3 | $35.4M | Buy |
498,446
+405
| +0.1% | +$28.7K | 0.04% | 329 |
|
|
2016
Q2 | $24.4M | Sell |
498,041
-86,706
| -15% | -$4.24M | 0.03% | 376 |
|
|
2016
Q1 | $37M | Sell |
584,747
-170,641
| -23% | -$10.8M | 0.04% | 329 |
|
|
2015
Q4 | $84.7M | Buy |
755,388
+9,724
| +1% | +$1.09M | 0.08% | 205 |
|
|
2015
Q3 | $71.8M | Buy |
745,664
+4,412
| +0.6% | +$425K | 0.07% | 234 |
|
|
2015
Q2 | $75.9M | Buy |
741,252
+5,638
| +0.8% | +$577K | 0.07% | 257 |
|
|
2015
Q1 | $45.7M | Buy |
735,614
+1,912
| +0.3% | +$119K | 0.04% | 338 |
|
|
2014
Q4 | $32.2M | Sell |
733,702
-24,864
| -3% | -$1.09M | 0.03% | 384 |
|
|
2014
Q3 | $42.9M | Buy |
758,566
+540,405
| +248% | +$30.6M | 0.04% | 356 |
|
|
2014
Q2 | $9.79M | Sell |
218,161
-65,059
| -23% | -$2.92M | 0.01% | 471 |
|
|
2014
Q1 | $13.8M | Buy |
+283,220
| New | +$13.8M | 0.01% | 468 |
|